article thumbnail

FDA Approvals: September 2022 Recap

Digital Pharmacist

CDER relies on its understanding of science and regulatory procedures to support and provide advice to pharmaceutical companies in testing and manufacturing, to then bring these new therapies to the market to aid patients and their health. Date of Approval: 9/30/2022. Date of Approval: 9/29/2022.

FDA 75
article thumbnail

Market cap growth surges for over half of the top biopharmaceutical companies in 2022

Pharmaceutical Technology

The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. Pfizer maintained its third-place position in the market in 2022, reporting a market capitalization of $287.6

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward

ISPE

2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward. Wed, 11/02/2022 - 07:32. 2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward. 2 November 2022. Trudy Patterson. iSpeak Blog. Susan Sandler. President, U.S. Business Unit and U.S. Country Head.

article thumbnail

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients

ISPE

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. Tue, 11/01/2022 - 06:49. 2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. 1 November 2022. He presented on “Quality: A Key Ingredient for Stable Pharmaceutical Supply Chains.”.

FDA 98
article thumbnail

Over-the-Counter Birth Control Pills: FDA Considering HRA Pharma’s Opill

Birth Control Pharmacist

Polling from Data for Progress in 2022 shows that the majority of Americans, regardless of political affiliation, support making birth control available over the counter. In June 2022, the AMA urged the FDA to approve an OTC contraceptive method with no age restriction. The FDA review process is expected to take about 10 months.

FDA 52
article thumbnail

Why Are FDA Inspections So Ineffective and Disappointing?

The People's Pharmacy

Why, then, are FDA inspections abroad so infrequent and disappointing? FDA Inspections Suspended: During the COVID pandemic, the Food and Drug Administration suspended its inspections at most foreign pharmaceutical facilities. Even under the best of conditions, the FDA never inspects all foreign pharmaceutical plants annually.

FDA 72
article thumbnail

Five things to watch as the Biosimilars market heats up in 2022

pharmaphorum

And already in the first quarter of 2022, the FDA approved a third filgrastim biosimilar, Releuko. Here are five things I have my eye on in 2022. In September of 2021, the FDA approved Byooviz , which references Roche and Novartis’ blockbuster eye drug Lucentis. market is just beginning to heat up.

FDA 59